An upregulation in CYP2E1 has also been associated with leptinemia, reduced adiponectin levels, and insulin resistance in NAFLD (Aubert et al., 2011). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.